In this study, by using objectively quantitated Ki67 protein levels to replace Ki67 score in the surrogate assay, we showed that inherent subjectivity and inconsistency of IHC analysis limited significantly the performance of the surrogate assay for Luminal-like breast cancer patients. Here, MKI67 is linked to breast carcinoma.